Cargando…

Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive storage of fatty acids in the form of triglycerides in hepatocytes. It is most prevalent in western countries and includes a wide range of clinical and histopathological findings, namely from simple steatosis to steatohepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katsarou, Angeliki, Moustakas, Ioannis I, Pyrina, Iryna, Lembessis, Panagiotis, Koutsilieris, Michael, Chatzigeorgiou, Antonios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267690/ https://www.ncbi.nlm.nih.gov/pubmed/32536770 http://dx.doi.org/10.3748/wjg.v26.i17.1993

Ejemplares similares

Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice Independently of Obesity
por: Moustakas, Ioannis I., et al.
Publicado: (2021)

Fate of Adipose Progenitor Cells in Obesity-Related Chronic Inflammation
por: Pyrina, Iryna, et al.
Publicado: (2020)

Significance of Circulating Cell-Free DNA Species in Non-Alcoholic Fatty Liver Disease
por: Chrysavgis, Lampros, et al.
Publicado: (2021)

Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
por: Legaki, Aigli-Ioanna, et al.
Publicado: (2022)

The Significance of Circulating Cell-Free DNA Markers in Chronic Hepatitis B Patients with Hepatocellular Carcinoma
por: Papatheodoridi, Alkistis, et al.
Publicado: (2021)

Frailty in metabolic syndrome, focusing on nonalcoholic fatty liver disease
por: Karakousis, Nikolaos D., et al.
Publicado: (2022)

Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research
por: Flessa, Christina-Maria, et al.
Publicado: (2022)

Significance of Circulating Cell-Free DNA Biomarkers in HBeAg-Negative Chronic Hepatitis B Virus Infection and Their Changes after Treatment Initiation
por: Karakousis, Nikolaos D., et al.
Publicado: (2023)

Hyperlipidemia as an Instigator of Inflammation: Inaugurating New Approaches to Vascular Prevention
por: Ridker, Paul M.
Publicado: (2012)

The Effects of Mechanical Loading Variations on the Hypertrophic, Anti-Apoptotic, and Anti-Inflammatory Responses of Differentiated Cardiomyocyte-like H9C2 Cells
por: Zevolis, Evangelos, et al.
Publicado: (2022)

Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
por: Tanwar, Sudeep, et al.
Publicado: (2020)

Endothelial cells instigate sepsis
por: Bashyam, Hema
Publicado: (2008)

Lipid loop instigates arthritis
por: Van Epps, Heather L.
Publicado: (2006)

Microscopic Organisms as Instigators of Disease
por: Raushenberg, Ch.
Publicado: (1872)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease
por: Puengel, Tobias, et al.
Publicado: (2022)

Effect of Mechanical Loading of Senescent Myoblasts on Their Myogenic Lineage Progression and Survival
por: Moustogiannis, Athanasios, et al.
Publicado: (2022)

Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Jambulingam, Nila, et al.
Publicado: (2023)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Melanocytes as Instigators and Victims of Oxidative Stress
por: Denat, L., et al.
Publicado: (2014)

Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging
por: Li, Yuan, et al.
Publicado: (2022)

Occupational Safety Analysis for COVID-Instigated Repurposed Manufacturing Lines: Use of Nanomaterials in Injection Moulding
por: Damilos, Spyridon, et al.
Publicado: (2022)

Metabolic Syndrome Is Associated With Advanced Liver Fibrosis Among Pediatric Patients With Non-alcoholic Fatty Liver Disease
por: Ting, Yi-Wen, et al.
Publicado: (2019)

Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018)

The Liver Cancer Immune Microenvironment: Emerging Concepts for Myeloid Cell Profiling with Diagnostic and Therapeutic Implications
por: Arvanitakis, Konstantinos, et al.
Publicado: (2023)

The Effects of Muscle Cell Aging on Myogenesis
por: Moustogiannis, Athanasios, et al.
Publicado: (2021)

Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
por: Campos-Murguía, Alejandro, et al.
Publicado: (2020)

Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Honda, Yasushi, et al.
Publicado: (2020)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver disease
por: Kranidiotis, Georgios, et al.
Publicado: (2013)

Alcohol and Metabolic-associated Fatty Liver Disease
por: Sun, Fu-Rong, et al.
Publicado: (2021)

The change catalyst: successfully instigating sustainable change
por: Macpherson, Campbell
Publicado: (2017)

Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease
por: Bellanti, Francesco, et al.
Publicado: (2022)

Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease
por: Cheah, Mark CC, et al.
Publicado: (2017)

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
por: Rios, Rafael S., et al.
Publicado: (2020)

Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Olteanu, Vasile-Andrei, et al.
Publicado: (2022)

Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE((-/-)) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
por: Nasiri-Ansari, Narjes, et al.
Publicado: (2021)

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
por: Nobili, Valerio, et al.
Publicado: (2009)

Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non-alcoholic fatty liver disease mouse model
por: Lu, Yulei, et al.
Publicado: (2019)

Liver ASK1 protects from non‐alcoholic fatty liver disease and fibrosis
por: Challa, Tenagne D, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e7rc1n0skn3bi7hsltv3mu71kp